Financials data is unavailable for this security.
View more
Year on year China Pharma Holdings Inc had revenues fall -13.48% from 8.10m to 7.01m, though the company grew net income from a loss of 3.97m to a smaller loss of 3.08m.
| Gross margin | -25.89% |
|---|---|
| Net profit margin | -70.48% |
| Operating margin | -67.31% |
| Return on assets | -29.39% |
|---|---|
| Return on equity | -74.89% |
| Return on investment | -59.89% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at China Pharma Holdings Inc fell by 606.13k. Cash Flow from Financing totalled 73.15k or 1.04% of revenues. In addition the company used 699.69k for operations while cash used for investing totalled 11.52k.
| Cash flow per share | -0.1582 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.4317 |
|---|---|
| Tangible book value per share | 0.1757 |
More ▼
Balance sheet in USDView more
| Current ratio | 0.8432 |
|---|---|
| Quick ratio | 0.2449 |
| Total debt/total equity | 0.537 |
|---|---|
| Total debt/total capital | 0.3494 |
More ▼
